A citation-based method for searching scientific literature

Henriette Strøm Kahr, Ole B Christiansen, Signe Juul Riddersholm, Inger L Gade, Christian Torp-Pedersen, Aage Knudsen, Ole Thorlacius-Ussing. J Thromb Haemost 2021
Times Cited: 1







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Extended thromboprophylaxis with low-molecular weight heparin (LMWH) following abdominopelvic cancer surgery.
Marc Carrier, Alon D Altman, Normand Blais, Artemis Diamantouros, Deanna McLeod, Uthaman Moodley, Christine Nguyen, Stephanie Young, Frank Schwenter. Am J Surg 2019
14
100

Apixaban to Prevent Venous Thromboembolism in Patients with Cancer.
Marc Carrier, Karim Abou-Nassar, Ranjeeta Mallick, Vicky Tagalakis, Sudeep Shivakumar, Ariah Schattner, Philip Kuruvilla, Danny Hill, Silvana Spadafora, Katerine Marquis,[...]. N Engl J Med 2019
304
100

Three-month mortality rate and clinical predictors in patients with venous thromboembolism and cancer. Findings from the RIETE registry.
Gualberto Gussoni, Stefania Frasson, Micaela La Regina, Pierpaolo Di Micco, Manuel Monreal. Thromb Res 2013
110
100

High incidence of silent venous thromboembolism before treatment in ovarian cancer.
T Satoh, A Oki, K Uno, M Sakurai, H Ochi, S Okada, R Minami, K Matsumoto, Y O Tanaka, H Tsunoda,[...]. Br J Cancer 2007
99
100


Incidence of venous thromboembolism following the neoadjuvant chemotherapy regimen for epithelial type of ovarian cancer.
Devendra Manik Chavan, Zhen Huang, Kun Song, Leela Rani Haricharan Parimi, Xing Sheng Yang, Xiangning Zhang, Peishu Liu, Jie Jiang, Youzhong Zhang, Beihua Kong,[...]. Medicine (Baltimore) 2017
10
100

The Khorana score for prediction of venous thromboembolism in cancer patients: a systematic review and meta-analysis.
Frits I Mulder, Matteo Candeloro, Pieter W Kamphuisen, Marcello Di Nisio, Patrick M Bossuyt, Noori Guman, Kirsten Smit, Harry R Büller, Nick van Es. Haematologica 2019
81
100

Incidence and Timing of Thromboembolic Events in Patients With Ovarian Cancer Undergoing Neoadjuvant Chemotherapy.
Patricia S Greco, Ali A Bazzi, Karen McLean, R Kevin Reynolds, Ryan J Spencer, Carolyn M Johnston, J Rebecca Liu, Shitanshu Uppal. Obstet Gynecol 2017
23
100

High IL-6 levels in ascitic fluid correlate with reactive thrombocytosis in patients with epithelial ovarian cancer.
G Gastl, M Plante, C L Finstad, G Y Wong, M G Federici, N H Bander, S C Rubin. Br J Haematol 1993
90
100

Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients.
Alok A Khorana, Charles W Francis, Eva Culakova, Nicole M Kuderer, Gary H Lyman. Cancer 2007
483
100

Meta-Analysis of VTE Risk: Ovarian Cancer Patients by Stage, Histology, Cytoreduction, and Ascites at Diagnosis.
Kristin S Weeks, Emma Herbach, Megan McDonald, Mary Charlton, Marin L Schweizer. Obstet Gynecol Int 2020
5
100

Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer.
Ignace Vergote, Claes G Tropé, Frédéric Amant, Gunnar B Kristensen, Tom Ehlen, Nick Johnson, René H M Verheijen, Maria E L van der Burg, Angel J Lacave, Pierluigi Benedetti Panici,[...]. N Engl J Med 2010
100

Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy.
Anne Ws Rutjes, Ettore Porreca, Matteo Candeloro, Emanuele Valeriani, Marcello Di Nisio. Cochrane Database Syst Rev 2020
1
100

Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30-year population-based study.
John A Heit, Catie E Kobbervig, Andra H James, Tanya M Petterson, Kent R Bailey, L Joseph Melton. Ann Intern Med 2005
703
100


Procoagulant activity in high grade serous ovarian cancer patients following neoadjuvant chemotherapy-The role of the activated protein C pathway.
Mark P Ward, Feras Abu Saadeh, Sharon A O'Toole, John J O'Leary, Noreen Gleeson, Lucy A Norris. Thromb Res 2021
1
100

Prognosis of cancers associated with venous thromboembolism.
H T Sørensen, L Mellemkjaer, J H Olsen, J A Baron. N Engl J Med 2000
100

Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy.
A A Khorana, C W Francis, E Culakova, N M Kuderer, G H Lyman. J Thromb Haemost 2007
834
100

Incidence of venous thromboembolism in patients with cancer - a cohort study using linked United Kingdom databases.
Alex J Walker, Tim R Card, Joe West, Colin Crooks, Matthew J Grainge. Eur J Cancer 2013
235
100


Development and validation of a predictive model for chemotherapy-associated thrombosis.
Alok A Khorana, Nicole M Kuderer, Eva Culakova, Gary H Lyman, Charles W Francis. Blood 2008
100

Venous thromboembolism in ovarian cancer: incidence, risk factors and impact on survival.
Feras Abu Saadeh, Lucy Norris, Sharon O'Toole, Noreen Gleeson. Eur J Obstet Gynecol Reprod Biol 2013
52
100

Platelet effects on ovarian cancer.
Ashley N Davis, Vahid Afshar-Kharghan, Anil K Sood. Semin Oncol 2014
35
100

Incidence of venous thrombosis in a large cohort of 66,329 cancer patients: results of a record linkage study.
J W Blom, J P M Vanderschoot, M J Oostindiër, S Osanto, F J M van der Meer, F R Rosendaal. J Thromb Haemost 2006
413
100

Beyond prophylaxis: Extended risk of venous thromboembolism following primary debulking surgery for ovarian cancer.
Beth E Wagner, Carrie L Langstraat, Michaela E McGree, Amy L Weaver, Shikha Sarangi, Bahareh Mokri, Sean C Dowdy, William A Cliby, Amanika Kumar, Jamie N Bakkum-Gamez. Gynecol Oncol 2019
16
100

Mechanisms and biomarkers of cancer-associated thrombosis.
Ann S Kim, Alok A Khorana, Keith R McCrae. Transl Res 2020
10
100


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.